Jeffrey A. Feinstein, MD, MPH
Academic Appointments
- Associate Professor - Med Center Line, Pediatrics - Cardiology
- Member, Child Health Research Institute
- Member, Bio-X
- Associate Professor - Med Center Line (By courtesy), Bioengineering
Key Documents
Contact Information
-
Clinical Offices
Heart Center 725 Welch Road Suite 120 Palo Alto, CA 94304 Tel Work (650) 721-2121 Fax (650) 497-8422Practices at Stanford Hospital and Clinics and Lucile Packard Children's Hospital
- Academic Offices
Personal Information Email Tel (650) 723-7913 Tel (650) 725-2297Not for medical emergencies or patient use
Professional Overview
Clinical Focus
- Pediatric Cardiology
- Congenital Heart Defects
- Pulmonary Hypertension
- Pulmonary Vascular Disease
- Pulmonary Vascular Abnormalities
- Cardiac Catheterization
Administrative Appointments
- Director, Pediatric Cardiology Inpatient Ward, Stanford University Medical Center (2011 - present)
- Director, Pediatric Cardiology Training Program, Stanford University Medical School (2009 - present)
- Director, Vera Moulton Wall Center for Pulmonary Vascular Disease, Stanford University Medical Center (2000 - present)
Professional Education
| Fellowship: | Children's Hospital National Medical Center DC (1997) |
| Board Certification: | Pediatric Cardiology, American Board of Pediatric Cardiology (1998) |
| Fellowship: | Children's Hospital Boston MA (1998) |
| Residency: | Children's Hospital National Medical Center DC (1994) |
| MS: | Duke University, Biomedical Engineering (1987) |
| Medical Education: | New York Medical College NY (1991) |
Postdoctoral Advisees
Claudia Algaze-Yojay, Rachel Hopper, Lindsey Malloy-Walton, Shreya Moodley, James Priest, Shreya Sheth, Heather Sun
Graduate & Fellowship Program Affiliations
Scientific Focus
Current Research Interests
Research interests include (1) computer simulation and modeling of cardiovascular physiology with specific attention paid to congenital heart disease and its treatment, and (2) the evaluation and treatment of pulmonary hypertension/pulmonary vascular disease and structural abnormalities of the pulmonary arteries as seen, for example, in Alagille Syndrome.
In the area of computational modeling, projects are underway in three areas: (1) examination of alterations in blood flow and vessel mechanics caused by coarctation (narrowing) of the aorta and the use of computational modeling to compare surgical and transcatheter methods of treatment, (2) creation of a computational model of the entire pulmonary vascular tree and computational modeling of various disease states including pulmonary artery stenosis and pulmonary hypertension as a disease stratification tool and better predict responses to therapy, and (3) the use of computational modeling to examine flow characteristics and energy efficiency at rest and varying degrees of exercise in patients who have undergone total cavopulmonary connection.
Publications
- Children with pulmonary arterial hypertension and prostanoid therapy: Long-term hemodynamics. J Heart Lung Transplant. 2013; (5): 546-52
- Chronic effects of pulmonary artery stenosis on hemodynamic and structural development of the lungs. Am J Physiol Lung Cell Mol Physiol. 2013; (1): L17-28
- Computational fluid dynamic simulations for determination of ventricular workload in aortic arch obstructions. J Thorac Cardiovasc Surg. 2013; (2): 489-495.e1
- Food and Drug Administration (FDA) Postmarket Reported Side Effects and Adverse Events Associated with Pulmonary Hypertension Therapy in Pediatric Patients. Pediatr Cardiol. 2013
- Implications of the U.S. Food and Drug Administration warning against the use of sildenafil for the treatment of pediatric pulmonary hypertension. Am J Respir Crit Care Med. 2013; (6): 572-5
- Optimization of a y-graft design for improved hepatic flow distribution in the fontan circulation. J Biomech Eng. 2013; (1): 011002
Help